Literature DB >> 12193056

Role of endothelin during experimental Trypanosoma cruzi infection in rats.

Elizabeth R S Camargos1, Conceição R S Machado, Antonio L Teixeira, Lamara L V Rocha, Anderson J Ferreira, Alvair P Almeida, Matthias Barton, Mauro M Teixeira.   

Abstract

Chagas' disease is caused by the intracellular protozoan Trypanosoma cruzi. Here we have investigated the role of endothelin-1 in T. cruzi acute infection in rats, using the orally active ET(A) receptor antagonist BSF-461314. Treatment with BSF-461314 markedly increased parasitaemia, but animals managed to control the infection by day 15. Histopathological analysis of heart tissue at the end of the acute phase showed greater numbers of parasite nests in BSF-461314-treated animals. The perfusion of isolated rat hearts from infected animals with bradykinin failed to induce an increase, and actually reduced, coronary blood flow. Pretreatment with BSF-461314 prevented changes in coronary flow induced by T. cruzi infection. Together these results demonstrate that endothelin-1, through ET(A) receptor activation, contributes to the protective immune response against acute T. cruzi infection. Moreover, these data suggest that endothelin-1 is a mediator of impaired endothelium-dependent vasomotion in the coronary microcirculation associated with acute T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193056     DOI: 10.1042/CS103S064S

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  1 in total

1.  The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.

Authors:  Minxian Dai; Brandi Freeman; Fernando P Bruno; Henry J Shikani; Herbert B Tanowitz; Louis M Weiss; Sandra E Reznik; Ralph A Stephani; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2012-07-17       Impact factor: 5.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.